References
- Adhikary S, Eilers M (2005). Transcriptional regulation and transformation by Myc proteins. Nat Rev Mol Cell Biol, 6, 635-45. https://doi.org/10.1038/nrm1703
- Alizadeh AA, Eisen MB, Davis RE, et al (2000). Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature, 403, 503-11. https://doi.org/10.1038/35000501
- Allan LA, Clarke PR (2009). Apoptosis and autophagy: Regulation of caspase-9 by phosphorylation. FEBS J, 276, 6063-73. https://doi.org/10.1111/j.1742-4658.2009.07330.x
- Alpen B, Robbecke J, Wundisch T, Stolte M, Neubauer A (2001). Helicobacter pylori eradication therapy in gastric high grade non Hodgkin's lymphoma (NHL). Ann Hematol, 80, 106-7.
- Baraniskin A, Deckert M, Schulte-Altedorneburg G, Schlegel U, Schroers R (2012). Current strategies in the diagnosis of diffuse large B-cell lymphoma of the central nervous system. Br J Haematol, 156, 421-32. https://doi.org/10.1111/j.1365-2141.2011.08928.x
- Bea S, Zettl A, Wright G, et al (2005). Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction. Blood, 106, 3183-90. https://doi.org/10.1182/blood-2005-04-1399
- Bende RJ, Smit LA, van Noesel CJ (2007). Molecular pathways in follicular lymphoma. Leukemia, 21, 18-29. https://doi.org/10.1038/sj.leu.2404426
- Berget E, Helgeland L, Lehmann AK, et al (2012). Primary diffuse large B-cell lymphoma of the dura without systemic recurrence four years after diagnosis and successful therapy. Acta Oncol, 52, 1047-9.
- Biasoli I, Morais JC, Scheliga A, et al (2005). CD10 and Bcl- 2 expression combined with the International Prognostic Index can identify subgroups of patients with diffuse largecell lymphoma with very good or very poor prognoses. Histopathology, 46, 328-33. https://doi.org/10.1111/j.1365-2559.2005.02099.x
- Bouillet P, Metcalf D, Huang DC, et al (1999). Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science, 286, 1735-8. https://doi.org/10.1126/science.286.5445.1735
- Charbonneau B, Maurer MJ, Fredericksen ZS, et al (2012). Germline variation in complement genes and event-free survival in follicular and diffuse large B-cell lymphoma. Am J Hematol, 87, 880-5. https://doi.org/10.1002/ajh.23273
- Dyer MJ (2003). The pathogenetic role of oncogenes deregulated by chromosomal translocation in B-cell malignancies. Int J Hematol, 77, 315-20. https://doi.org/10.1007/BF02982637
- Gouda I, Nada O, Ezzat S, et al (2010). Immunohistochemical detection of hepatitis C virus (genotype 4) in B-cell NHL in an Egyptian population: correlation with serum HCV-RNA. Appl Immunohistochem Mol Morphol, 18, 29-34. https://doi.org/10.1097/PAI.0b013e3181ae9e82
- Guo YL, Dong LL, Gao L, et al (2012). Clinical significance of rapid detecting bone marrow BCL2/IGH and BCL6/IGH fusion genes in patients with diffuse large B cell lymphoma by multiplex PCR. Zhongguo Shi Yan Xue Ye Xue Za Zhi, 20, 1370-3.
- Harada H, Quearry B, Ruiz-Vela A, Korsmeyer SJ (2004). Survival factor-induced extracellular signal-regulated kinase phosphorylates BIM, inhibiting its association with BAX and proapoptotic activity. Proc Natl Acad Sci USA, 101, 15313-7. https://doi.org/10.1073/pnas.0406837101
- Ibrahim A, Abdel Rahman H, Khorshied M, et al (2012). Tumor necrosis factor alpha-308 and Lymphotoxin alpha+252 genetic polymorphisms and the susceptibility to non- Hodgkin lymphoma in Egypt. Leuk Res, 36, 694-8. https://doi.org/10.1016/j.leukres.2011.11.016
- Iqbal J, Greiner TC, Patel K, et al (2007). Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma. Leukemia, 21, 2332-43. https://doi.org/10.1038/sj.leu.2404856
- Jardin F, Ruminy P, Bastard C, Tilly H (2007). The BCL6 protooncogene: a leading role during germinal center development and lymphomagenesis. Pathol Biol, 55, 73-83. https://doi.org/10.1016/j.patbio.2006.04.001
- Jardin F, Ruminy P, Parmentier F, et al (2005). Clinical and biological relevance of single-nucleotide polymorphisms and acquired somatic mutations of the BCL6 first intron in follicular lymphoma. Leukemia, 19, 1824-30. https://doi.org/10.1038/sj.leu.2403915
- Kanavaros P, De Bruin PC, Briere J, Meijer CJ, Gaulard P (1995). Epstein-Barr virus (EBV) in extranodal T-cell non-Hodgkin's lymphomas (T-NHL). Identification of nasal T-NHL as a distinct clinicopathological entity associated with EBV. Leuk Lymphoma, 18, 27-34. https://doi.org/10.3109/10428199509064919
- Khanna KK, Wie T, Song Q, et al (1996). Expression of p53, bcl-2, bax, bcl-x2 and c-myc in radiation-induced apoptosis in Burkitt's lymphoma cells. Cell Death Differ, 3, 315-22.
- Killebrew D, Shiramizu B (2004). Pathogenesis of HIVassociated non-Hodgkin lymphoma. Curr HIV Res, 2, 215-21. https://doi.org/10.2174/1570162043351237
- Kuppers R (2005). Mechanisms of B-cell lymphoma pathogenesis. Nat Rev Cancer, 5, 251-62. https://doi.org/10.1038/nrc1589
- Kuppers R, Dalla-Favera R (2001). Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene, 20, 5580-94. https://doi.org/10.1038/sj.onc.1204640
- Lewin N, Aman P, Mellstedt H, et al (1990). Epstein Barr virus (EBV) carrying cells in blood of Hodgkin's disease (HD) and non-Hodgkin lymphoma (NHL) patients with high antibody titers against EBV capsid antigens (VCA). Anticancer Res, 10, 1213-6.
- Lossos IS, Akasaka T, Martinez-Climent JA, Siebert R, Levy R (2003). The BCL6 gene in B-cell lymphomas with 3q27 translocations is expressed mainly from the rearranged allele irrespective of the partner gene. Leukemia, 17, 1390-7. https://doi.org/10.1038/sj.leu.2402997
- Lossos IS, Jones CD, Warnke R, et al (2001). Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma. Blood, 98, 945-51. https://doi.org/10.1182/blood.V98.4.945
- Marcucci F, Mele A (2011). Hepatitis viruses and non-Hodgkin lymphoma: epidemiology, mechanisms of tumorigenesis, and therapeutic opportunities. Blood, 117, 1792-8. https://doi.org/10.1182/blood-2010-06-275818
- Martinez-Delgado B, Melendez B, Cuadros M, et al (2004). Expression profiling of T-cell lymphomas differentiates peripheral and lymphoblastic lymphomas and defines survival related genes. Clin Cancer Res, 10, 4971-82. https://doi.org/10.1158/1078-0432.CCR-04-0269
- Mey U, Hitz F, Lohri A, et al (2012). Diagnosis and treatment of diffuse large B-cell lymphoma. Swiss Med Wkly, 142, 0.
- Morton LM, Purdue MP, Zheng T, et al (2009). Risk of non- Hodgkin lymphoma associated with germline variation in genes that regulate the cell cycle, apoptosis, and lymphocyte development. Cancer Epidemiol Biomarkers Prev, 18, 1259-70. https://doi.org/10.1158/1055-9965.EPI-08-1037
- Muramatsu M, Akasaka T, Kadowaki N, et al (1996). Rearrangement of the BCL6 gene in B-cell lymphoid neoplasms: comparison with lymphomas associated with BCL2 rearrangement. Br J Haematol, 93, 911-20. https://doi.org/10.1046/j.1365-2141.1996.d01-1728.x
- Nasr AS, Sami RM, Ibrahim NY (2012). Methylenetetrahydrofolate reductase gene polymorphisms (677C>T and 1298A>C) in Egyptian patients with non-Hodgkin lymphoma. J Cancer Res Ther, 8, 355-60. https://doi.org/10.4103/0973-1482.103512
- Naz E, Mirza T, Danish F (2011). Clinicopathologic evaluation of subgroups of diffuse large B cell lymphoma by immunohistochemistry. Asian Pac J Cancer Prev, 12, 3335-9.
- Ohno H (2006). Pathogenetic and clinical implications of non-immunoglobulin; BCL6 translocations in B-cell non- Hodgkin's lymphoma. J Clin Exp Hematop, 46, 43-53. https://doi.org/10.3960/jslrt.46.43
- Pasqualucci L, Compagno M, Houldsworth J, et al (2006). Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma. J Exp Med, 203, 311-7. https://doi.org/10.1084/jem.20052204
- Porcu P, Nichols CR (1998). Evaluation and management of the "new" lymphoma entities: mantle cell lymphoma, lymphoma of mucosa-associated lymphoid tissue, anaplastic large-cell lymphoma, and primary mediastinal B-cell lymphoma. Curr Probl Cancer, 22, 283-368. https://doi.org/10.1016/S0147-0272(98)90003-4
- Reed JC, Miyashita T, Krajewski S, et al (1996). Bcl-2 family proteins and the regulation of programmed cell death in leukemia and lymphoma. Cancer Treat Res, 84, 31-72. https://doi.org/10.1007/978-1-4613-1261-1_3
- Staudt LM, Dave S (2005). The biology of human lymphoid malignancies revealed by gene expression profiling. Adv Immunol, 87, 163-208. https://doi.org/10.1016/S0065-2776(05)87005-1
- Tate G, Kishimoto K, Hirayama Y, Suzuki T, Mitsuya T (2009). A novel missense mutation of the XBP1 gene in diffuse large B-cell lymphoma. Cancer Genet Cytogenet, 190, 131-3. https://doi.org/10.1016/j.cancergencyto.2009.01.003
- Tilly H, Vitolo U, Walewski J, et al (2012). Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 23, 778-82.
- van Doorn R, Zoutman WH, Dijkman R, et al (2005). Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73. J Clin Oncol, 23, 3886-96. https://doi.org/10.1200/JCO.2005.11.353
- Wright G, Tan B, Rosenwald A, et al (2003). A gene expressionbased method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma. Proc Natl Acad Sci USA, 100, 9991-6. https://doi.org/10.1073/pnas.1732008100
- Zani VJ, Asou N, Jadayel D, et al (1996). Molecular cloning of complex chromosomal translocation t(8;14;12) (q24.1;q32.3;q24.1) in a Burkitt lymphoma cell line defines a new gene (BCL7A) with homology to caldesmon. Blood, 87, 3124-34.
- Zantl N, Weirich G, Zall H, et al (2007). Frequent loss of expression of the pro-apoptotic protein Bim in renal cell carcinoma: evidence for contribution to apoptosis resistance. Oncogene, 26, 7038-48. https://doi.org/10.1038/sj.onc.1210510
- Zhang Y, Lan Q, Rothman N, et al (2005). A putative exonic splicing polymorphism in the BCL6 gene and the risk of non-Hodgkin lymphoma. J Natl Cancer Inst, 97, 1616-8. https://doi.org/10.1093/jnci/dji344
Cited by
- Type Distribution of Lymphomas in Lebanon: Five-Year Single Institution Experience vol.15, pp.14, 2014, https://doi.org/10.7314/APJCP.2014.15.14.5825
- Clinicopathologic and Survival Characteristics of Childhood and Adolescent Non Hodgkin's Lymphoma in Yazd, Iran vol.15, pp.4, 2014, https://doi.org/10.7314/APJCP.2014.15.4.1585
- Red Meat Intake and Risk of Non-Hodgkin Lymphoma: A Meta-Analysis vol.15, pp.23, 2014, https://doi.org/10.7314/APJCP.2014.15.23.10421
- Lack of Association between Using Aspirin and Development of Non-Hodgkins Lymphoma: A Meta-analysis vol.16, pp.2, 2015, https://doi.org/10.7314/APJCP.2015.16.2.787
- The Polymerase Chain Reaction in Diagnosis of Small B-Cell Non-Hodgkin Lymphomas vol.17, pp.2, 2016, https://doi.org/10.7314/APJCP.2016.17.2.491